| PERIOD ENDING | 30-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 324,608 | 482,763 | 673,794 | 477,481 | | Cost of Revenue | 272,218 | 401,770 | 561,724 | 401,584 | | | Gross Profit | 52,390 | 80,993 | 112,070 | 75,897 | | | Operating Expenses | | Research Development |
-
| 69,067 | 68,118 | 128,153 | | Selling General and Administrative | 60,793 |
-
|
-
| (64,851) | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (8,403) | 11,926 | 43,952 | 12,595 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,290 | 523 | 806 | 687 | | Earnings Before Interest And Taxes | (7,113) | 12,449 | 44,758 | 13,282 | | Interest Expense | 6,476 | 6,827 | 7,709 | 8,714 | | Income Before Tax | (13,589) | 5,622 | 37,049 | 4,568 | | Income Tax Expense | (4,902) | 297 | 11,638 | 1,376 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,687) | 5,325 | 25,411 | 3,192 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,687) | 5,325 | 25,411 | 3,192 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,687) | $5,325 | $25,411 | $3,192 |
|
0.51% Nasdaq 
0.31 (1.51%) 
Income Statement
